The Chart of the Day belongs to AxoGen (AXGN). I found the regenerative medicine stock by using Barchart to sort today’s 52 Week New High list first for the highest Wei...
A recurring pattern of the past few decades involves governments promising to limit their borrowing, only to discover that hardly anyone cares. So target dates slip, bonds are issu...
The headline data this month showed some growth in consumer income and spending – with expenditures year-over-year growth far outpacing income growth – and the savings ...
Biotechnology sector has corrected over 10%. Poor earnings of larger biotechs knocked the wind out of the sector. An imminent catalyst can push the sector higher, recovering recent...
For the second day in a row, precious metals are being pounded as gold joins silver back below its 200-day moving-average… Knocking gold back to 3-week lows… All of whi...
I joined Peggy Tuck Wednesday on Straight Talk Money. The topic of conversation? Bitcoin, of course. The cryptocurrency has gone parabolic, which raises the question: How high can ...
Much has been made of Factor Investing, and even Vanguard is launching a suite of actively-managed factor ETFs. But even now, with Vanguard offering factor ETFs, there are many in...
A dispassionate look at the quantities and flows of fiat dollars tells us much about the current state of the US economy, and therefore prospects for the dollar itself. This is a s...
In their second estimate of the US GDP for the third quarter of 2017, the Bureau of Economic Analysis (BEA) reported that the US economy was growing at a +3.30% annual rate, up +...
Currently, stock markets are flying high, courtesy of a favorable GDP growth rate, rising disposable income, an improving labor market with unemployment rate at a 16-year low, rise...